Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

Zanamivir oral delivery: possibilities revisited.

Shanmugam S.

Ther Deliv. 2015;6(4):403-5. doi: 10.4155/tde.15.9. No abstract available.

PMID:
25996038
2.

Granulation techniques and technologies: recent progresses.

Shanmugam S.

Bioimpacts. 2015;5(1):55-63. doi: 10.15171/bi.2015.04. Epub 2015 Feb 18. Review.

3.

Enhanced oral bioavailability of paclitaxel by solid dispersion granulation.

Shanmugam S, Im HT, Sohn YT, Kim YI, Park JH, Park ES, Woo JS.

Drug Dev Ind Pharm. 2015;41(11):1864-76. doi: 10.3109/03639045.2015.1018275. Epub 2015 Mar 16.

PMID:
25775012
4.

Zanamivir oral delivery: enhanced plasma and lung bioavailability in rats.

Shanmugam S, Im HT, Sohn YT, Kim KS, Kim YI, Yong CS, Kim JO, Choi HG, Woo JS.

Biomol Ther (Seoul). 2013 Mar;21(2):161-9. doi: 10.4062/biomolther.2013.010.

5.

Sildenafil vaginal suppositories: preparation, characterization, in vitro and in vivo evaluation.

Shanmugam S, Kim YH, Park JH, Im HT, Sohn YT, Kim KS, Kim YI, Yong CS, Kim JO, Choi HG, Woo JS.

Drug Dev Ind Pharm. 2014 Jun;40(6):803-12. doi: 10.3109/03639045.2013.788011. Epub 2013 Jun 19.

PMID:
23781859
6.

Biofilm formation by Streptococcus pyogenes: modulation of exopolysaccharide by fluoroquinolone derivatives.

Shafreen RM, Srinivasan S, Manisankar P, Pandian SK.

J Biosci Bioeng. 2011 Oct;112(4):345-50. doi: 10.1016/j.jbiosc.2011.06.013. Epub 2011 Jul 20.

PMID:
21764368
7.

New clopidogrel napadisilate salt and its solid dispersion with improved stability and bioequivalence to the commercial clopidogrel bisulphate salt in beagle dogs.

Kim YI, Kim KS, Suh KH, Shanmugam S, Woo JS, Yong CS, Choi HG.

Int J Pharm. 2011 Aug 30;415(1-2):129-39. doi: 10.1016/j.ijpharm.2011.05.059. Epub 2011 May 27.

PMID:
21645599
8.

Solid self-nanoemulsifying drug delivery system (S-SNEDDS) containing phosphatidylcholine for enhanced bioavailability of highly lipophilic bioactive carotenoid lutein.

Shanmugam S, Baskaran R, Balakrishnan P, Thapa P, Yong CS, Yoo BK.

Eur J Pharm Biopharm. 2011 Oct;79(2):250-7. doi: 10.1016/j.ejpb.2011.04.012. Epub 2011 Apr 29.

PMID:
21550401
9.

Enhanced bioavailability and retinal accumulation of lutein from self-emulsifying phospholipid suspension (SEPS).

Shanmugam S, Park JH, Kim KS, Piao ZZ, Yong CS, Choi HG, Woo JS.

Int J Pharm. 2011 Jun 30;412(1-2):99-105. doi: 10.1016/j.ijpharm.2011.04.015. Epub 2011 Apr 16.

PMID:
21540096
10.

Preparation and evaluation of Cremophor-free paclitaxel solid dispersion by a supercritical antisolvent process.

Park JH, Yan YD, Chi SC, Hwang DH, Shanmugam S, Lyoo WS, Woo JS, Yong CS, Choi HG.

J Pharm Pharmacol. 2011 Apr;63(4):491-9. doi: 10.1111/j.2042-7158.2010.01218.x. Epub 2011 Mar 1.

PMID:
21401600
11.

Physicochemical stability, pharmacokinetic, and biodistribution evaluation of paclitaxel solid dispersion prepared using supercritical antisolvent process.

Shanmugam S, Park JH, Chi SC, Yong CS, Choi HG, Woo JS.

Drug Dev Ind Pharm. 2011 Jun;37(6):628-37. doi: 10.3109/03639045.2010.533682. Epub 2011 Mar 14.

PMID:
21401339
12.

Antitumor efficacy of solid dispersion of paclitaxel prepared by supercritical antisolvent process in human mammary tumor xenografts.

Shanmugam S, Park JH, Chi SC, Yong CS, Choi HG, Woo JS.

Int J Pharm. 2011 Jan 17;403(1-2):130-5. doi: 10.1016/j.ijpharm.2010.10.033. Epub 2010 Oct 23.

PMID:
20974239
13.

Synthesis and in vitro antimicrobial evaluation of novel fluoroquinolone derivatives.

Srinivasan S, Beema Shafreen RM, Nithyanand P, Manisankar P, Pandian SK.

Eur J Med Chem. 2010 Dec;45(12):6101-5. doi: 10.1016/j.ejmech.2010.09.036. Epub 2010 Sep 22.

PMID:
20933306
14.

Novel self-nanoemulsifying drug delivery system for enhanced solubility and dissolution of lutein.

Yoo JH, Shanmugam S, Thapa P, Lee ES, Balakrishnan P, Baskaran R, Yoon SK, Choi HG, Yong CS, Yoo BK, Han K.

Arch Pharm Res. 2010 Mar;33(3):417-26. doi: 10.1007/s12272-010-0311-5. Epub 2010 Mar 30.

PMID:
20361307
15.

Physicochemical characterization and skin permeation of liposome formulations containing clindamycin phosphate.

Shanmugam S, Song CK, Nagayya-Sriraman S, Baskaran R, Yong CS, Choi HG, Kim DD, Woo JS, Yoo BK.

Arch Pharm Res. 2009 Jul;32(7):1067-75. doi: 10.1007/s12272-009-1713-0. Epub 2009 Jul 31.

PMID:
19641889
16.

Theoretical and experimental studies of vibrational spectra and thermal analysis of 2-nitroaniline and its cation.

Azhagiri S, Ramkumaar GR, Jayakumar S, Kumaresan S, Arunbalaji R, Gunasekaran S, Srinivasan S.

J Mol Model. 2010 Jan;16(1):87-94. doi: 10.1007/s00894-009-0522-1. Epub 2009 Jun 6.

PMID:
19504134
17.

Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery.

Balakrishnan P, Shanmugam S, Lee WS, Lee WM, Kim JO, Oh DH, Kim DD, Kim JS, Yoo BK, Choi HG, Woo JS, Yong CS.

Int J Pharm. 2009 Jul 30;377(1-2):1-8. doi: 10.1016/j.ijpharm.2009.04.020. Epub 2009 Apr 24.

PMID:
19394413
18.

Skin penetration and retention of L-ascorbic acid 2-phosphate using multilamellar vesicles.

Yoo J, Shanmugam S, Song CK, Kim DD, Choi HG, Yong CS, Woo JS, Yoo BK.

Arch Pharm Res. 2008 Dec;31(12):1652-8. doi: 10.1007/s12272-001-2164-4. Epub 2008 Dec 20.

PMID:
19099237
19.

The effect of coenzyme Q10 on the pharmacokinetic parameters of theophylline.

Baskaran R, Shanmugam S, Nagayya-Sriraman S, Kim JH, Jeong TC, Yong CS, Choi HG, Yoo BK.

Arch Pharm Res. 2008 Jul;31(7):938-44. doi: 10.1007/s12272-001-1250-1. Epub 2008 Aug 14.

PMID:
18704339
20.

Mixed micellar nanoparticle of amphotericin B and poly styrene-block-poly ethylene oxide reduces nephrotoxicity but retains antifungal activity.

Han K, Miah MA, Shanmugam S, Yong CS, Choi HG, Kim JA, Yoo BK.

Arch Pharm Res. 2007 Oct;30(10):1344-9.

PMID:
18038914

Supplemental Content

Loading ...
Support Center